Atlas Venture Life Science Advisors, LLC Spero Therapeutics, Inc. Transaction History
Atlas Venture Life Science Advisors, LLC
- $606 Million
- Q4 2024
A detailed history of Atlas Venture Life Science Advisors, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Atlas Venture Life Science Advisors, LLC holds 305,255 shares of SPRO stock, worth $250,309. This represents 0.05% of its overall portfolio holdings.
Number of Shares
305,255
Previous 402,885
24.23%
Holding current value
$250,309
Previous $539,000
41.19%
% of portfolio
0.05%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding SPRO
# of Institutions
50Shares Held
13.8MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.75MShares$3.08 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$1.45 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.11 Million14.54% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$878,9250.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny975KShares$799,2150.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $28.8M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...